Literature DB >> 30237839

Recommendations for the safe use and handling of oral anticancer drugs in community pharmacy: A pan-Canadian consensus guideline.

Kathy Vu1,2,3,4,5,6,7,8,9,10,11,12, Philip Emberley1,2,3,4,5,6,7,8,9,10,11,12, Erika Brown1,2,3,4,5,6,7,8,9,10,11,12, Rick Abbott1,2,3,4,5,6,7,8,9,10,11,12, Justin J Bates1,2,3,4,5,6,7,8,9,10,11,12, Venetia Bourrier1,2,3,4,5,6,7,8,9,10,11,12, Kathryn Djordjevic1,2,3,4,5,6,7,8,9,10,11,12, Julie Greenall1,2,3,4,5,6,7,8,9,10,11,12, Mova Leung1,2,3,4,5,6,7,8,9,10,11,12, Mark Pasetka1,2,3,4,5,6,7,8,9,10,11,12, Louise Paquet1,2,3,4,5,6,7,8,9,10,11,12, Heather Logan1,2,3,4,5,6,7,8,9,10,11,12.   

Abstract

Year:  2018        PMID： 30237839      PMCID： PMC6141941          DOI： 10.1177/1715163518767942

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  11 in total

1.  ISOPP standards of practice. Safe handling of cytotoxics.

Authors: 
Journal:  J Oncol Pharm Pract       Date:  2007       Impact factor: 1.809

2.  Safe handling and administration of antineoplastic chemotherapy.

Authors:  Seth Eisenberg
Journal:  J Infus Nurs       Date:  2009 Jan-Feb

Review 3.  NCCN Task Force Report: Oral chemotherapy.

Authors:  Saul N Weingart; Elizabeth Brown; Peter B Bach; Kirby Eng; Shirley A Johnson; Timothy M Kuzel; Terry S Langbaum; R Donald Leedy; Raymond J Muller; Lee N Newcomer; Susan O'Brien; Denise Reinke; Mark Rubino; Leonard Saltz; Ronald S Walters
Journal:  J Natl Compr Canc Netw       Date:  2008-03       Impact factor: 11.908

4.  ReCAP: Comparison of Independent Error Checks for Oral Versus Intravenous Chemotherapy.

Authors:  Melissa C Griffin; Rachel E Gilbert; Larry H Broadfield; Anthony E Easty; Patricia L Trbovich; Melissa C Griffin; Rachel E Gilbert; Larry H Broadfield; Anthony E Easty; Patricia L Trbovich
Journal:  J Oncol Pract       Date:  2015-09-29       Impact factor: 3.840

5.  Safe handling of oral chemotherapeutic agents in clinical practice: recommendations from an international pharmacy panel.

Authors:  Susan Goodin; Niesha Griffith; Beth Chen; Karen Chuk; Mikael Daouphars; Christian Doreau; Rinku A Patel; Rowena Schwartz; Maria José Tamés; Robert Terkola; Barbara Vadnais; Debbie Wright; Klaus Meier
Journal:  J Oncol Pract       Date:  2011-01       Impact factor: 3.840

6.  US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards.

Authors:  Saul N Weingart; Justin W Li; Junya Zhu; Laurinda Morway; Sherri O Stuver; Lawrence N Shulman; Michael J Hassett
Journal:  J Oncol Pract       Date:  2011-12-06       Impact factor: 3.840

Review 7.  Safe practices and financial considerations in using oral chemotherapeutic agents.

Authors:  Sylvia B Bartel
Journal:  Am J Health Syst Pharm       Date:  2007-05-01       Impact factor: 2.637

8.  Safe handling and administration considerations of oral anticancer agents in the clinical and home setting.

Authors:  Joanne Lester
Journal:  Clin J Oncol Nurs       Date:  2012-12       Impact factor: 1.027

Review 9.  Safe handling of oral antineoplastic medications: Focus on targeted therapeutics in the home setting.

Authors:  Yaakov Cass; Thomas H Connor; Alexander Tabachnik
Journal:  J Oncol Pharm Pract       Date:  2016-03-22       Impact factor: 1.809

10.  Oral antineoplastic handling at health care institutions in the United States: survey of nurses and pharmacists.

Authors:  David J Reeves; Teresa C Kam; Susan H Storey
Journal:  Hosp Pharm       Date:  2013-04
View more
  2 in total

1.  Real-World Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies During the COVID-19 Pandemic.

Authors:  Rodrigo Murteira; Sónia Romano; Inês Teixeira; Carolina Bulhosa; Sérgio Sousa; Maria Inês Conceição; Anabela Fonseca-Silva; Humberto Martins; António Teixeira Rodrigues
Journal:  Value Health       Date:  2022-04-12       Impact factor: 5.101

2.  Evaluation of acute and sub-acute toxicity profile of 5-methylcoumarin-4β-glucoside in mice.

Authors:  Bilyaminu Abubakar; Alhassan Muhammad Alhassan; Ibrahim Malami; Dawoud Usman; Yaaqub Abiodun Uthman; Kehinde Ahmad Adeshina; Mutolib Olabayo Olatubosun; Mustapha Umar Imam
Journal:  Toxicol Rep       Date:  2022-03-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.